MongoDB Inc’s Disappointing Guidance Leads to 6.31% Share Drop

Date:

MongoDB Inc (NASDAQ: MDB) shares experienced a decline on Friday following the company’s fourth-quarter report release with lower-than-expected guidance. The analysts have revised their forecasts, offering various perspectives on MongoDB’s performance and outlook.

DA Davidson analyst Rudy Kessinger upgraded MongoDB’s rating from Neutral to Buy and raised the price target to $430. Although the company reported strong fourth-quarter results, the shares dipped due to disappointing fiscal 2025 guidance, projecting growth and operating margins below consensus estimates.

Truist Securities analyst Miller Jump maintained a Buy rating with a reduced price target of $475. Jump noted that MongoDB’s results exceeded expectations but expressed concerns about a significant deceleration in the upcoming year, potentially impacting margin gains.

KeyBanc Capital Markets analyst Eric Heath reiterated an Overweight rating, adjusting the price target to $490. Heath highlighted solid fourth-quarter revenues and increased confidence from management, attributing it to stable market conditions and consumption patterns.

Analyst Kash Rangan reaffirmed a Buy rating with a lowered price target of $440, emphasizing MongoDB’s outperformance in subscription revenue, operating margin, and free cash flows. Rangan acknowledged the stock’s decline due to revised expectations for top and bottom-line growth.

Mizuho Securities analyst Siti Panigrahi maintained a Neutral rating and reduced the price target to $380. Panigrahi praised MongoDB’s strong quarter but expressed concerns about the company’s fiscal 2025 guidance falling below consensus due to tough comparables.

On the other hand, Needham analyst Mike Cikos reiterated a Buy rating and reduced the price target to $465, describing MongoDB’s revenue growth guidance as disappointing. Cikos viewed the company’s outlook as conservative, emphasizing its historical trend of providing cautious full-year guidance.

See also  Quantum Computing Stocks: QUBT Stands Out Among Hedge Funds' Top Picks

JMP Securities analyst Patrick Walravens maintained a Market Outperform rating with a price target of $440, highlighting MongoDB’s impressive quarterly results but expressing caution regarding the significantly below-expectation guidance for the future.

In conclusion, MongoDB’s performance in the fourth quarter was commendable, but the concerns about future growth and margin gains have led to mixed reactions from analysts. Despite the challenges ahead, analysts maintain varying perspectives on MongoDB’s potential to navigate the evolving market landscape. As of the latest update, MongoDB shares were down by 6.31% to $386.

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Advait Gupta
Advait Gupta
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.